To further characterize the gene sets that are enriched in SCLC tumours, we derived an RB–E2F score, using chromatin immunoprecipitation and sequencing (ChIP–seq) data from the CISTROME database42. This evidence concerns the gene RB1 and small cell lung carcinoma.